BR

Biswarup Roy

Active Director Director DIN 08216517
DIN 08216517 First appointment Sep 2018 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2018
Shareholding value •••• Premium profile

About Biswarup Roy

Data last updated:

Biswarup Roy is a Director at Liminal Pharma Private Limited (since 2018). The company operates in Chemicals. Liminal Pharma Private Limited reported revenue of ₹13.2 Lakh (FY 2022).

DIN 08216517
Primary Designation Director
Industry Chemicals
First Appointment 05 Sep 2018
Oldest Company Age 8 yrs
Largest company Liminal Pharma Private Limited · ₹13.2 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Liminal Pharma Private Limited U24239WB2018PTC227658
Director05 Sep 20182018₹13.2 Lakh (FY 2022)Active

Board colleagues of Biswarup Roy

Directorship timeline

Open interactive timeline →
Liminal Pharma Private Limited
Premium access

Shareholding and investment profile for Biswarup Roy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Biswarup Roy

Biswarup Roy currently holds 1 directorship: Liminal Pharma Private Limited (Director, since 05 Sep 2018, revenue ₹13.2 Lakh (FY 2022)).

Biswarup Roy was first appointed on 05 Sep 2018 as Director at Liminal Pharma Private Limited.

The current boards of Biswarup Roy's companies include Rajib Ghosh (Liminal Pharma Private Limited), Surajit Kar (Liminal Pharma Private Limited), Surya Sankar Dasgupta (Liminal Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available